Drug reference
isosorbide dinitrate/hydralazine
Vasodilator · Agent for heart failure
VasodilatorAgent for heart failure
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Isosorbide dinitrate, an organic nitrate, dilates large blood vessels (venous capacitance and arterial conductance vessels), primarily reducing preload. Hydralazine is a direct vasodilator whose mechanism of action is unresolved but may prevent nitrate tolerance by reducing ROS-mediated inactivation of nitric oxide.
Indications
heart failure in African Americans
Dosing
- Adult
- Fixed combination formulation contains 37.5 mg hydralazine and 20 mg ISDN and is uptitrated to a target dose of two tablets, thrice daily.
Contraindications
- PDE5 inhibitors
Side effects
Common
dizzinessheadachenauseaflushingpalpitationstachycardiaangina pectoris
Serious
- hypotension
- drug-induced lupus-like syndrome
Related guidelines
Other Vasodilator drugs
Ask House about isosorbide dinitrate/hydralazine
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team